[WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.](https://wbbsec.com/press-releases/wbb-securities-invites-you-to-attend-the-upcoming-demy-colton-virtual-salon-titled-seven-years-after-fda-approval-what-have-we-learned-about-cell-and-gene-therapies/)
[WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.](https://wbbsec.com/press-releases/wbb-securities-invites-you-to-attend-the-upcoming-demy-colton-virtual-salon-titled-seven-years-after-fda-approval-what-have-we-learned-about-cell-and-gene-therapies/)

On Thursday, October 19, 2023, the WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations titled “A Tale of Two Pandemics: 1889 & 2019, Insights for Pandemic Preparedness.”

On Thursday, October 19, 2023, the WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations titled “A Tale of Two Pandemics: 1889 & 2019, Insights for Pandemic Preparedness.”
The forum will examine how responses to prior influenza pathogens predicated global responses to Covid.

Read More about On Thursday, October 19, 2023, the WBB Research Institute and the Foreign Policy Association will sponsor an important forum at the United Nations titled “A Tale of Two Pandemics: 1889 & 2019, Insights for Pandemic Preparedness.”

WBB SECURITIES PRESIDENT STEVE BROZAK WILL MODERATE A PANEL AT THE BIOFUTURE CONFERENCE ON FRIDAY, OCTOBER 6, 2023

On Friday, October 6, Steve Brozak, Managing Partner and President of WBB Securities will moderate a panel discussion titled: “Infectious Disease: From Neglect to Respect Made Possible by New Technologies” at the BioFuture forum in New York City. 

Read More about WBB SECURITIES PRESIDENT STEVE BROZAK WILL MODERATE A PANEL AT THE BIOFUTURE CONFERENCE ON FRIDAY, OCTOBER 6, 2023